Sun Pharma Seals Deal: Sun Pharma To Acquire Remaining Stake Of Taro for $43/shr | Stock News
0In a strategic move, Sun Pharma is set to acquire the remaining 21.52% outstanding shares of Taro for $43 per share, totaling $347.73 million. The acquisition price represents a substantial 48% premium to Taro's closing price on May 25, 2023, marking its last trading day before Sun Pharma's initial non-binding bid. The merger, anticipated to conclude in the first half of 2024, will render Taro a privately held company, and its shares will no longer be listed on the NYSE. This culmination follows nearly 17 years of negotiations, empowering Sun Pharma in its dermatology business operations primarily in the United States and Canada.
#sunpharma #taro #stocknews
Subscribe To ET Now For Latest Updates On Stocks, Business, Trading | ► https://goo.gl/SEjvK3
Subscribe Now To Our Network Channels :-
Times Now : http://goo.gl/U9ibPb
The NewsHour Debate : http://goo.gl/LfNgFF
To Stay Updated Download the Times Now App :-
Android Google Play : https://goo.gl/zJhWjC
Apple App Store : https://goo.gl/d7QBQZ
Social Media Links :-
Twitter - http://goo.gl/hA0vDt
Facebook - http://goo.gl/5Lr4mC
G+ - http://goo.gl/hYxrmj
Website - www.etnownews.com